BD Marks 70 Years of Manufacturing and Innovation at Sandy, Utah Facility
BD (Becton, Dickinson and Company) has marked 70 years of manufacturing in Sandy, Utah, a key part of the company’s U.S. manufacturing network and a critical source of medical technologies healthcare providers and patients depend on for daily care worldwide. Founded in 1956 as Deseret Pharmaceuticals, the Sandy site has played a significant role in the evolution of vascular access technology.
Today, the 650,000-square-foot facility employs more than 1,000 people and produces peripheral intravenous catheters used to deliver medications, fluids, and treatments to patients. Combining advanced molding, extrusion, and tubing capabilities, the site manufactures hundreds of millions of catheters and billions of molded components each year, serving healthcare systems across the United States and beyond. BD has invested more than $100 million in the Sandy site over the past five years to expand production capacity, modernize operations, and support future innovation.
BD leaders, elected officials, employees, and community partners gathered at the Sandy facility to celebrate its 70-year history. That legacy is reflected in the generations of employees who have built careers at the site, including 34 employees with more than 40 years of service and more than 80 who have spent at least 25 years with the company. As part of the celebration, BD announced a $10,000 grant to the Maliheh Free Clinic, a nonprofit providing free healthcare services to uninsured and underserved people across Utah. The grant builds on a partnership that began in 2024. Since 2022, BD and Sandy employees have contributed more than $170,000 to local organizations, including FIRST Robotics Utah, Make-A-Wish Utah, and the Mabuhay Deseret Foundation. BD also partners with local schools through internships and educational programs designed to spark interest in medical technology and advanced manufacturing careers.
Eric Borin, Worldwide President of Medication Delivery Solutions at BD, said for 70 years, generations of Sandy employees have brought tremendous skill, pride, and purpose to work that touches patient care every day. Borin noted that their commitment to safety, quality, innovation, and operational excellence helps ensure clinicians can rely on the products made there during some of the most fundamental moments in care delivery, and that he is incredibly proud of the team and the impact they make for patients, healthcare providers, and the community.
Utah is also a key center for BD research, development, and manufacturing, with more than 1,500 employees statewide, including at the company’s business site in Salt Lake City. In 2025 alone, 165 patents were granted to BD Utah inventors. Jefferson Moss, Commissioner of the Governor’s Office of Economic Development, said BD’s legacy in Utah and in medtech worldwide is tremendous, and that the state is proud of all the company has built in Sandy over the past 70 years. Moss noted that Utah is scaling its ability to manufacture essential technologies and products the country needs, and that companies like BD and its talented workforce deserve congratulations as they advance these efforts.
